UB Paderborn / Katalog / Suche / in CDI

S2k guidelines: management of large-vessel vasculitis

Zeitschrift für Rheumatologie, 2020-11, Vol.79 (Suppl 3), p.67-95

2020

Link zum Volltext

Verfügbarkeit prüfen

S2k guidelines (executive summary): management of large-vessel vasculitis

Zeitschrift für Rheumatologie, 2020-11, Vol.79 (9), p.937-942

2020

Link zum Volltext

Verfügbarkeit prüfen

Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography

The journal of clinical endocrinology and metabolism, 2005-06, Vol.90 (6), p.3392-3400

2005

Link zum Volltext

Verfügbarkeit prüfen

Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer

Annals of oncology, 2009-06, Vol.20 (6), p.1057-1061

2009

Link zum Volltext

Verfügbarkeit prüfen

Involving patients as research partners exemplified by the development and evaluation of a communication-skills training programme (KOKOS-Rheuma)

Zeitschrift für Rheumatologie, 2021-03, Vol.80 (2), p.132-139

2021

Link zum Volltext

Verfügbarkeit prüfen

6101 POSTER Promising Results After Radionuclide Therapy With 177LU-DOTA-octreotate in Patients With Disseminated Neuroendocrine Hindgut Tumours

European journal of cancer (1990), 2011, Vol.47, p.S422-S422

2011

Link zum Volltext

Verfügbarkeit prüfen

Segmental colonic transit studies: comparison of a radiological and a scintigraphic method

Colorectal disease, 2007-05, Vol.9 (4), p.344-351

2007

Link zum Volltext

Verfügbarkeit prüfen

S2k-Leitlinie: Management der Großgefäßvaskulitiden

Zeitschrift für Rheumatologie, 2020-11, Vol.79 (Suppl 3), p.67-95

2020

Link zum Volltext

Verfügbarkeit prüfen

Individualized dosimetry in patients undergoing therapy with (177)Lu-DOTA-D-Phe (1)-Tyr (3)-octreotate

European journal of nuclear medicine and molecular imaging, 2010-02, Vol.37 (2), p.212-225

2010

Link zum Volltext

Verfügbarkeit prüfen

S2k-Leitlinie (Kurzfassung): Management der Großgefäßvaskulitiden

Zeitschrift für Rheumatologie, 2020-11, Vol.79 (9), p.937-942

2020

Link zum Volltext

Verfügbarkeit prüfen

Whole-Body 11C-5-Hydroxytryptophan Positron Emission Tomography as a Universal Imaging Technique for Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and Computed Tomography

The journal of clinical endocrinology and metabolism, 2005-06, Vol.90 (6), p.3392-3400

2005

Link zum Volltext

Verfügbarkeit prüfen

High Success Rate of Parathyroid Reoperation may be Achieved with Improved Localization Diagnosis

World journal of surgery, 2008-05, Vol.32 (5), p.774-781

2008

Link zum Volltext

Verfügbarkeit prüfen

Selective internal radiation therapy in patients with progressive neuroendocrine liver metastases

European journal of nuclear medicine and molecular imaging, 2016-07, Vol.43 (8), p.1425-1431

2016

Link zum Volltext

Verfügbarkeit prüfen

Hybrid SPECT-CT : An additional technique for sentinel node detection of patients with invasive bladder cancer

European urology, 2006-07, Vol.50 (1), p.83-91

2006

Link zum Volltext

Verfügbarkeit prüfen

177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated with Chemotherapy: Analysis of Outcome, Safety, and Their Determinants

Neuroendocrinology, 2021, Vol.111 (4), p.330-343

2021

Link zum Volltext

Verfügbarkeit prüfen

P2-09-01: First-in-Human Whole-Body HER2−Receptor Mapping Using Affibody Molecular Imaging

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P2-P2-09-01

2011

Link zum Volltext

Verfügbarkeit prüfen

Lessons on Tumour Response: Imaging during Therapy with (177)Lu-DOTA-octreotate. A Case Report on a Patient with a Large Volume of Poorly Differentiated Neuroendocrine Carcinoma

Theranostics, 2012, Vol.2 (5), p.459-471

2012

Link zum Volltext

Verfügbarkeit prüfen

Intra- and inter-rater reliability of endonasal activity estimation in granulomatosis with polyangiitis (Wegener´s)

Clinical and experimental rheumatology, 2012-01, Vol.30 (1 Suppl 70), p.S22

2012

Link zum Volltext

Verfügbarkeit prüfen

Kidney dosimetry during 177Lu-DOTATATE therapy in patients with neuroendocrine tumors: aspects on calculation and tolerance

Acta oncologica, 2018-04, Vol.57 (4), p.516-521

2018

Link zum Volltext

Verfügbarkeit prüfen

Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity

European journal of nuclear medicine and molecular imaging, 2018, Vol.45 (6), p.970-988

2018

Link zum Volltext

Verfügbarkeit prüfen

Minor changes in effective half-life during fractionated 177Lu-Octreotate therapy

Acta oncologica, 2012-01, Vol.51 (1), p.86-96

2012

Link zum Volltext

Verfügbarkeit prüfen

Detection of immune responses against urinary bladder cancer in sentinel lymph nodes

European urology, 2006, Vol.49 (1), p.59-70

2006

Link zum Volltext

Verfügbarkeit prüfen

Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with 177Lu-DOTATATE

Cancers, 2019-06, Vol.11 (7), p.909

2019

Link zum Volltext

Verfügbarkeit prüfen

Early prediction of response to first-line chemotherapy by sequential [[sup]18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer

Annals of oncology, 2009-06, Vol.20 (6), p.1057

2009

Link zum Volltext

Verfügbarkeit prüfen

MP-15.04

Urology (Ridgewood, N.J.), 2006-11, Vol.68, p.148-149

2006

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

S2k guidelines: management of large-vessel vasculitis

S2k guidelines (executive summary): management of large-vessel vasculitis

Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography

Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer

Involving patients as research partners exemplified by the development and evaluation of a communication-skills training programme (KOKOS-Rheuma)

6101 POSTER Promising Results After Radionuclide Therapy With 177LU-DOTA-octreotate in Patients With Disseminated Neuroendocrine Hindgut Tumours

Segmental colonic transit studies: comparison of a radiological and a scintigraphic method

S2k-Leitlinie: Management der Großgefäßvaskulitiden

Individualized dosimetry in patients undergoing therapy with (177)Lu-DOTA-D-Phe (1)-Tyr (3)-octreotate

S2k-Leitlinie (Kurzfassung): Management der Großgefäßvaskulitiden

Whole-Body 11C-5-Hydroxytryptophan Positron Emission Tomography as a Universal Imaging Technique for Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and Computed Tomography

High Success Rate of Parathyroid Reoperation may be Achieved with Improved Localization Diagnosis

Selective internal radiation therapy in patients with progressive neuroendocrine liver metastases

Hybrid SPECT-CT : An additional technique for sentinel node detection of patients with invasive bladder cancer

177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated with Chemotherapy: Analysis of Outcome, Safety, and Their Determinants

P2-09-01: First-in-Human Whole-Body HER2−Receptor Mapping Using Affibody Molecular Imaging

Lessons on Tumour Response: Imaging during Therapy with (177)Lu-DOTA-octreotate. A Case Report on a Patient with a Large Volume of Poorly Differentiated Neuroendocrine Carcinoma

Intra- and inter-rater reliability of endonasal activity estimation in granulomatosis with polyangiitis (Wegener´s)

Kidney dosimetry during 177Lu-DOTATATE therapy in patients with neuroendocrine tumors: aspects on calculation and tolerance

Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity

Minor changes in effective half-life during fractionated 177Lu-Octreotate therapy

Detection of immune responses against urinary bladder cancer in sentinel lymph nodes

Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with 177Lu-DOTATATE

Early prediction of response to first-line chemotherapy by sequential [[sup]18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer

MP-15.04

Suchergebnisse filtern